CSIMarket Company Name, Ticker, Competitors, else..
 
Syros Pharmaceuticals Inc   (SYRS)
Other Ticker:  
 
 

Syros Pharmaceuticals Inc Cash flow Statement Quarterly

SYRS



Select the Financial Report:   Period:   Fiscal Year:



New: More SYRS's historic Cash Flow >>

Cash flow Statement
(Quarterly, GAAP in millions $)

(Sep 30 2023)
9 Months 		(Jun 30 2023)
6 Months 		(Mar 31 2023)
3 Months 		(Dec 31 2022)
12 Months		 (Sep 30 2022)
9 Months
Income -100.19 -60.05 -23.79 -94.65 -89.88
Depreciation & amortization 1.90 1.29 0.64 2.71 2.00
Amortization of Other Assets - - - - -
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense - - - - -
Asset Impairment Charges 0.37 - - - -
Provision for Loan, Lease, and Other Losses - - - - -
Inventories Decrease /-Increase - - - - -
R & D, Environmental and Other Expense - - - - -
Gain (Loss) on Disposition of Assets, Total - - - - -
Share-based Compensation 8.71 5.46 2.65 11.41 8.51
Income (Loss) from Equity Method Investments - - - - -
Fair Value Adjustment of Warrants 0.08 -5.76 -8.87 -43.22 -12.47
Increase Decrease In Prepaid Expense And Other Current Assets 0.46 0.50 1.32 -1.47 -0.13
Increase Decrease In Contract With Customer Liability -4.19 -2.15 -1.09 -8.56 -6.59
Increase Decrease In Operating Lease Asset And Liabilities - - - -0.62 -0.41
Finance Lease Right Of Use Asset Amortization - - - 0.20 0.13
Operating Lease Expense 0.07 0.07 0.07 1.21 0.69
Income taxes - - - - -
Losses/ -gains on Investments net - - - - -
Increase (Decrease) in Accounts Receivable - - - - -
Increase (Decrease) in Accounts Payable -3.56 0.28 -3.62 2.77 0.32
Increase (Decrease) in Accrued Liabilities 3.52 -0.64 -4.22 2.35 3.73
Deferred Revenue and Customer Advances and Deposits - - - - -
Prepaid Expense and Other Assets - - - - -
Other Working Capital 3.24 3.12 0.70 -2.41 -0.73
Other Noncash Items - - - - -
Other net - - - - -
Payments for (Proceeds from) Other Operating Activities -1.57 -1.42 -0.70 5.95 5.77
Discontinued operations - - - - -
Net Cash flow from Operating Activities -91.15 -59.29 -36.90 -123.07 -91.98
Capital Expenditures -0.23 -0.23 -0.24 -1.24 -0.57
Sale of Capital Items - - - - -
Proceeds from Sale and Maturity of Marketable Securities 87.02 58.38 22.99 68.43 30.03
Payments to Acquire Marketable Securities -50.97 -50.97 -48.50 - -
Real Estate Investments - - - - -
Restricted Cash and Investments Increase (Decrease) - - - - -
Payments for (Proceeds from) Loans - - - - -
Payments for (Proceeds from) Deposits - - - - -
Payments for (Proceeds from) Other Investments - - - - -
Payments for (Proceeds from) Federal Reserve and Federal Home Loan Bank - - - - -
Acquisition Net of Cash Acquired - - - - -
Interest in Subsidiaries and Affiliates - - - - -
Sale of businesses - - - - -
Accounts payable - - - - -
Receivables - - - - -
Payments for (Proceeds from) Other Investing Activities - - - - -
Other Net 0.00 0.00 - - -
Discontinued operations - - - - -
Net Cash flow from Investing Activities 35.82 7.18 -25.75 67.19 29.46
Short-term debt Net - - - - -
Other borrowing transactions - - - - -
Long-term debt - borrowings - - - - -
Long-term debt - repayments - - - - -
Federal Home Loan Bank and Federal Funds - - - - -
Issuances/ -repurchases of Comm. Stock 0.14 0.14 - 0.22 0.11
Partnership and Parent Transactions - - - - -
Issuances/ -repurchases of Pref. Stock - - - - -
Deposits, Annuities, Contract Holders Funds - - - - -
Other financing activities net - - - - -
Other net 0.00 - - 131.44 141.88
Proceeds From Issuance Of Common Stock And Warrants In Public Offerings And Private Placements Net Of Issuance Costs - - - - -
Proceeds From Issuance Of Convertible Preferred Stock And Warrants Net Of Issuance Costs - - - - -
Proceeds From Issuance Of Common Stock Through Exercise Of Warrants - - - - -
Proceeds From Issuance Of Common Stock And Accompanying Warrants In Public Offerings And Private Placements Net Of Issuance Costs - - - - -
Proceeds From Issuance Of Convertible Preferred Stock And Accompanying Warrants In Public Offering Net Of Issuance Costs - - - - -
Proceeds From Issuance Of Common Stock In Public Offering Net Of Issuance Costs - - - - -
Payment Of Issuance Cost Related To Out Of Period Offering And Debt Issuance - - - - -
Payments On Financing Lease Obligations -0.06 -0.06 -0.05 - -
Proceeds From Issuance Of Common Stock And Warrants In Public Offering Net Of Issuance Costs - - - - -
Payment Of Issuance Cost Related To Out Of Period Offering - - - -0.02 -0.02
Payments On Financing And Capital Lease Obligations - - - -0.22 -0.14
Payment To Creditor Related To Debt Modification - - - - -
Payments of Dividends, Preferred Stock and Preference Stock - - - - -
Dividends paid - - - - -
Net Cash flow from Financing Activities 0.08 0.09 -0.05 131.05 141.75
Effect of exchange rate on cash flow - - - - -
Discontinued operations - - - - -
Free Cash Flow -91.38 -59.52 -37.14 -124.31 -92.55
Total Cash Flow -55.25 -52.03 -62.70 75.17 79.23




Untitled Document 





	
			
  

 







  

	  


 
    Help


	About us


	Advertise




			

  




CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  
    Copyright © 2024 CSIMarket, Inc. All rights
  reserved. 



Intraday data delayed per exchange requirements.  All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com